Zappia v. Myovant Sciences Ltd., et al.

Freshfields’ Litigation Team successfully represented Sumitovant Biopharma Limited. A shareholder’s attempt to challenge a $2.9 billion take-private merger between Sumitovant Biopharma Limited (Sumitovant, formerly known as...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Invest Bank’s Restructuring Plan

Freshfields Bruckhaus Deringer (Freshfields) advised Invest Bank P.S.C. on its capital restructuring plan. Invest Bank P.S.C. implemented a comprehensive capital restructuring plan, marking the first of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Alibaba Health’s $1.73bn Acquistion of Exclusive Rights to Provide Marketing Services from Alibaba Group

Freshfields Bruckhaus Deringer (Freshfields) advised Alibaba Health on its acquisition of an exclusive operating right from Alibaba Group to provide certain marketing services. Alibaba Health Information...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

EQT’s Acquisition of Zeus

Freshfields Advised Zeus on on the sale to EQT Private Equity. EQT X and Zeus Company, Inc., jointly announced that they have entered into a definitive...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Volkswagen Group €2.4bn Investment in Chinese Joint Venture with Horizon Robotics

Freshfields Bruckhaus Deringer (‘Freshfields’) advised Volkswagen Group on €2.4bn investment in China smart vehicle technology joint venture with Horizon Robotics. Volkswagen Group (through its subsidiary CARIAD)...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here